Keyphrases
Clinical Trials
65%
Olaparib
34%
Reporting Guidelines
34%
Clinical Trial Registry
34%
Risk-benefit
23%
Objective Response Rate
19%
Risk Outcomes
17%
Patient Outcomes
17%
Physical Medicine & Rehabilitation
17%
Selinexor
17%
Solid Malignancies
17%
Patient Benefit
17%
Drug Development
17%
Affordable Solution
17%
Patient Risk
17%
Cost-plus
17%
Anxiety Disorders
17%
Core Outcome Set
17%
Orthopedics
17%
Trialists
17%
Web-based Survey
17%
Cuban
17%
Drug Companies
17%
Medicare
17%
Physical Medicine
13%
Physical Rehabilitation
13%
Adverse Events
12%
Overall Survival
12%
Progression-free Survival
10%
Control Arm
10%
CiteScore
9%
Scopus
9%
New Indication
8%
Drug Manufacturer
8%
Ovarian Cancer
8%
Top 100
7%
Guideline Use
7%
Trial Registration
7%
Trial Characteristics
6%
PubMed
6%
Median Progression-free Survival
6%
Cochrane
6%
Embase
6%
MEDLINE
6%
Cumulative Costs
5%
Cost Savings
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Olaparib
34%
Cross Sectional Study
19%
Drug Development
17%
Selinexor
17%
Myositis
17%
Muscle Relaxant Agent
17%
Myalgia
17%
Anxiety Disorder
17%
Adverse Event
17%
Progression Free Survival
17%
Tablet
17%
Gout
17%
Malignant Neoplasm
12%
Overall Survival
12%
Ovary Cancer
8%
Pharmaceutical Manufacturing
8%
Medicine and Dentistry
Clinical Trial
51%
Olaparib
34%
Drug Therapy
21%
Health Care Cost
17%
Orthopedics
17%
Medicare
17%
Rehabilitation Engineering
17%
Malignant Neoplasm
12%
Ovarian Cancer
8%
Adverse Event
8%
Progression Free Survival
8%
